← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Horne William B.
Chief Executive Officer | Director | Officer
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001333268
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 7
- Purchases · 24M
- 10
- Average purchase
- $24.4K
- Median purchase
- $17.5K
- Gross purchase value
- $244.5K
Companies: Alzamend Neuro, Inc. | Hyperscale Data, Inc.
10 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-09-30 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $16.0K | Open filing |
| 2026-09-29 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $17.0K | Open filing |
| 2026-09-18 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $18.0K | Open filing |
| 2026-09-08 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $31.4K | Open filing |
| 2026-09-02 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $20.0K | Open filing |
| 2026-07-01 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $95.0K | Open filing |
| 2026-06-12 | Hyperscale Data, Inc. | GPUS | Chief Executive Officer | Officer | $34.0K | Open filing |
| 2025-03-27 | Alzamend Neuro, Inc. | ALZN | Director | $3.3K | Open filing |
| 2025-03-20 | Alzamend Neuro, Inc. | ALZN | Director | $4.9K | Open filing |
| 2025-03-19 | Alzamend Neuro, Inc. | ALZN | Director | $4.8K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 10Developing | 100.0% (10/10) | 40.0% (4/10) | -1.9% | +8.6% | -7.5% |
| 20D | 7Developing | 87.5% (7/8) | 0.0% (0/7) | -19.5% | -21.5% | -35.3% |
| 60D | 5Developing | 100.0% (5/5) | 0.0% (0/5) | -76.4% | -74.9% | -81.0% |
| 120D | 3Small Sample | 100.0% (3/3) | 0.0% (0/3) | -89.7% | -90.0% | -92.0% |
Research patterns
- First purchase in 12M
- 1/9
- Large purchase ≥ $100k
- 0/10
- Cluster buying · 15D
- 10/10
- Buying the dip
- 10/10
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.